Listed by the USPTO as CHEN, PO-CHIH
Tech Center 1600 • Art Units: 1621 1626 1654
This examiner grants 74% of resolved cases
CHEN, PO-CHIH is a USPTO patent examiner in tech center 1600 and art unit 1621. The record includes 775 resolved cases, an allowance rate of 74.3%, and a median of 885 days to allowance. The interview lift is 14.7%, indicating a positive but limited interview-associated effect compared with the overall allowance result.
The listed companies are Amtixbio Co. Ltd., Merck Patent GmbH, and LG Energy Solution Ltd. The listed firms are United One Law Group LLC, Morgan, Lewis & Bockius LLP (WA), and OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. The substantial case record supports using the figures for timing and allowance planning in related matters.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16954098 | HETEROCYCLIC COMPOUND FOR USE IN ELECTRONIC DEVICES | Final Rejection | Merck Patent GmbH |
| 18292092 | Compound and Method for Preparing Same | Final Rejection | LG Energy Solution, Ltd. |
| 18466599 | RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18666084 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | Non-Final OA | Sun Pharmaceutical Industries, Inc. |
| 17220974 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | Non-Final OA | Purdue Research Foundation |
| 17788809 | 1,3-BUTYLENE GLYCOL PRODUCT | Final Rejection | DAICEL CORPORATION |
| 18044977 | LINEAR AND CYCLIC AROMATIC OLIGOAMIDES, METHODS OF MAKING SAME, AND USES THEREOF | Final Rejection | The Research Foundation for The State University of New York |
| 18851289 | TREATING CANCER WITH SMALL MOLECULES THAT INHIBIT ACSS-2 | Non-Final OA | DREXEL UNIVERSITY |
| 18684397 | TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH TRADIPITANT | Non-Final OA | Vanda Pharmaceuticals Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy74.3% of resolved applications examined by Po-Chih Chen were allowed (775 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +14.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Po-Chih Chen took 885 days on average from filing to allowance.
Po-Chih Chen examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
